ASGN INC (ASGN) Fundamental Analysis & Valuation

NYSE:ASGN • US00191U1025

41.95 USD
-0.03 (-0.07%)
At close: Mar 4, 2026
41.95 USD
0 (0%)
After Hours: 3/4/2026, 8:09:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ASGN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Taking everything into account, ASGN scores 4 out of 10 in our fundamental rating. ASGN was compared to 86 industry peers in the IT Services industry. ASGN has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on ASGN.


Dividend Valuation Growth Profitability Health

4

1. ASGN Profitability Analysis

1.1 Basic Checks

  • ASGN had positive earnings in the past year.
  • In the past year ASGN had a positive cash flow from operations.
  • Each year in the past 5 years ASGN has been profitable.
  • ASGN had a positive operating cash flow in 4 of the past 5 years.
ASGN Yearly Net Income VS EBIT VS OCF VS FCFASGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • With a decent Return On Assets value of 3.53%, ASGN is doing good in the industry, outperforming 60.47% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 7.13%, ASGN is in the better half of the industry, outperforming 61.63% of the companies in the same industry.
  • ASGN has a Return On Invested Capital (5.92%) which is in line with its industry peers.
Industry RankSector Rank
ROA 3.53%
ROE 7.13%
ROIC 5.92%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASGN Yearly ROA, ROE, ROICASGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • The Profit Margin of ASGN (3.28%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of ASGN has declined.
  • The Operating Margin of ASGN (6.74%) is better than 60.47% of its industry peers.
  • ASGN's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 28.90%, ASGN is not doing good in the industry: 62.79% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of ASGN has remained more or less at the same level.
Industry RankSector Rank
OM 6.74%
PM (TTM) 3.28%
GM 28.9%
OM growth 3Y-13.5%
OM growth 5Y-6.34%
PM growth 3Y-21.31%
PM growth 5Y-13%
GM growth 3Y-1.16%
GM growth 5Y1.31%
ASGN Yearly Profit, Operating, Gross MarginsASGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ASGN Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ASGN is destroying value.
  • ASGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ASGN Yearly Shares OutstandingASGN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ASGN Yearly Total Debt VS Total AssetsASGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • ASGN has an Altman-Z score of 2.46. This is not the best score and indicates that ASGN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ASGN's Altman-Z score of 2.46 is in line compared to the rest of the industry. ASGN outperforms 52.33% of its industry peers.
  • ASGN has a debt to FCF ratio of 4.11. This is a neutral value as ASGN would need 4.11 years to pay back of all of its debts.
  • ASGN has a Debt to FCF ratio of 4.11. This is comparable to the rest of the industry: ASGN outperforms 58.14% of its industry peers.
  • ASGN has a Debt/Equity ratio of 0.64. This is a neutral value indicating ASGN is somewhat dependend on debt financing.
  • ASGN has a Debt to Equity ratio (0.64) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 4.11
Altman-Z 2.46
ROIC/WACC0.68
WACC8.74%
ASGN Yearly LT Debt VS Equity VS FCFASGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.99 indicates that ASGN should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.99, ASGN perfoms like the industry average, outperforming 59.30% of the companies in the same industry.
  • ASGN has a Quick Ratio of 1.99. This is a normal value and indicates that ASGN is financially healthy and should not expect problems in meeting its short term obligations.
  • ASGN's Quick ratio of 1.99 is in line compared to the rest of the industry. ASGN outperforms 59.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.99
ASGN Yearly Current Assets VS Current LiabilitesASGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ASGN Growth Analysis

3.1 Past

  • ASGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.00%.
  • The Earnings Per Share has been decreasing by -1.19% on average over the past years.
  • The Revenue has decreased by -2.91% in the past year.
  • ASGN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.59% yearly.
EPS 1Y (TTM)-13%
EPS 3Y-11.57%
EPS 5Y-1.19%
EPS Q2Q%-10.16%
Revenue 1Y (TTM)-2.91%
Revenue growth 3Y-4.58%
Revenue growth 5Y2.59%
Sales Q2Q%-0.5%

3.2 Future

  • Based on estimates for the next years, ASGN will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.36% on average per year.
  • The Revenue is expected to grow by 3.63% on average over the next years.
EPS Next Y11.48%
EPS Next 2Y14.71%
EPS Next 3Y16.36%
EPS Next 5YN/A
Revenue Next Year1.41%
Revenue Next 2Y3.16%
Revenue Next 3Y3.63%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ASGN Yearly Revenue VS EstimatesASGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
ASGN Yearly EPS VS EstimatesASGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

8

4. ASGN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.22 indicates a reasonable valuation of ASGN.
  • Based on the Price/Earnings ratio, ASGN is valued cheaply inside the industry as 86.05% of the companies are valued more expensively.
  • ASGN is valuated cheaply when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
  • ASGN is valuated reasonably with a Price/Forward Earnings ratio of 8.27.
  • Based on the Price/Forward Earnings ratio, ASGN is valued cheaper than 88.37% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of ASGN to the average of the S&P500 Index (25.11), we can say ASGN is valued rather cheaply.
Industry RankSector Rank
PE 9.22
Fwd PE 8.27
ASGN Price Earnings VS Forward Price EarningsASGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • ASGN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ASGN is cheaper than 86.05% of the companies in the same industry.
  • ASGN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ASGN is cheaper than 93.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.32
EV/EBITDA 7.53
ASGN Per share dataASGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • ASGN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ASGN's earnings are expected to grow with 16.36% in the coming years.
PEG (NY)0.8
PEG (5Y)N/A
EPS Next 2Y14.71%
EPS Next 3Y16.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ASGN Dividend Analysis

5.1 Amount

  • ASGN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ASGN Fundamentals: All Metrics, Ratios and Statistics

ASGN INC

NYSE:ASGN (3/4/2026, 8:09:01 PM)

After market: 41.95 0 (0%)

41.95

-0.03 (-0.07%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-04
Earnings (Next)04-21
Inst Owners101.19%
Inst Owner Change-4.13%
Ins Owners3.68%
Ins Owner Change10.71%
Market Cap1.79B
Revenue(TTM)3.98B
Net Income(TTM)130.70M
Analysts72.31
Price Target55.59 (32.51%)
Short Float %5.09%
Short Ratio3.34
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.35%
Min EPS beat(2)4.9%
Max EPS beat(2)5.79%
EPS beat(4)3
Avg EPS beat(4)2.24%
Min EPS beat(4)-5.06%
Max EPS beat(4)5.79%
EPS beat(8)7
Avg EPS beat(8)2.43%
EPS beat(12)9
Avg EPS beat(12)1.95%
EPS beat(16)12
Avg EPS beat(16)3.08%
Revenue beat(2)1
Avg Revenue beat(2)-0.39%
Min Revenue beat(2)-1.33%
Max Revenue beat(2)0.55%
Revenue beat(4)1
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-3.43%
Max Revenue beat(4)0.55%
Revenue beat(8)1
Avg Revenue beat(8)-1.55%
Revenue beat(12)1
Avg Revenue beat(12)-1.74%
Revenue beat(16)3
Avg Revenue beat(16)-1.32%
PT rev (1m)9.36%
PT rev (3m)3.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.11%
EPS NY rev (1m)1.02%
EPS NY rev (3m)1.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.24%
Revenue NY rev (1m)0.83%
Revenue NY rev (3m)0.83%
Valuation
Industry RankSector Rank
PE 9.22
Fwd PE 8.27
P/S 0.45
P/FCF 6.32
P/OCF 5.5
P/B 0.98
P/tB N/A
EV/EBITDA 7.53
EPS(TTM)4.55
EY10.85%
EPS(NY)5.07
Fwd EY12.09%
FCF(TTM)6.63
FCFY15.82%
OCF(TTM)7.63
OCFY18.19%
SpS93.33
BVpS42.93
TBVpS-18.26
PEG (NY)0.8
PEG (5Y)N/A
Graham Number66.29
Profitability
Industry RankSector Rank
ROA 3.53%
ROE 7.13%
ROCE 8.29%
ROIC 5.92%
ROICexc 6.16%
ROICexgc 38.45%
OM 6.74%
PM (TTM) 3.28%
GM 28.9%
FCFM 7.11%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-13.5%
OM growth 5Y-6.34%
PM growth 3Y-21.31%
PM growth 5Y-13%
GM growth 3Y-1.16%
GM growth 5Y1.31%
F-Score5
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 4.11
Debt/EBITDA 3.1
Cap/Depr 39.53%
Cap/Sales 1.07%
Interest Coverage 4.1
Cash Conversion 86.65%
Profit Quality 216.76%
Current Ratio 1.99
Quick Ratio 1.99
Altman-Z 2.46
F-Score5
WACC8.74%
ROIC/WACC0.68
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13%
EPS 3Y-11.57%
EPS 5Y-1.19%
EPS Q2Q%-10.16%
EPS Next Y11.48%
EPS Next 2Y14.71%
EPS Next 3Y16.36%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.91%
Revenue growth 3Y-4.58%
Revenue growth 5Y2.59%
Sales Q2Q%-0.5%
Revenue Next Year1.41%
Revenue Next 2Y3.16%
Revenue Next 3Y3.63%
Revenue Next 5YN/A
EBIT growth 1Y-14.38%
EBIT growth 3Y-17.46%
EBIT growth 5Y-3.91%
EBIT Next Year71.07%
EBIT Next 3Y26.6%
EBIT Next 5YN/A
FCF growth 1Y-26.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.72%
OCF growth 3YN/A
OCF growth 5YN/A

ASGN INC / ASGN FAQ

What is the fundamental rating for ASGN stock?

ChartMill assigns a fundamental rating of 4 / 10 to ASGN.


What is the valuation status of ASGN INC (ASGN) stock?

ChartMill assigns a valuation rating of 8 / 10 to ASGN INC (ASGN). This can be considered as Undervalued.


How profitable is ASGN INC (ASGN) stock?

ASGN INC (ASGN) has a profitability rating of 4 / 10.


How financially healthy is ASGN INC?

The financial health rating of ASGN INC (ASGN) is 4 / 10.


What is the expected EPS growth for ASGN INC (ASGN) stock?

The Earnings per Share (EPS) of ASGN INC (ASGN) is expected to grow by 11.48% in the next year.